Back to Search
Start Over
The global impact of the COVID-19 pandemic on the management and course of chronic urticaria
- Source :
- Kocatürk, E, Salman, A, Cherrez-Ojeda, I, Criado, P R, Peter, J, Comert-Ozer, E, Abuzakouk, M, Agondi, R C, Al-Ahmad, M, Altrichter, S, Arnaout, R, Arruda, L K, Asero, R, Bauer, A, Ben-Shoshan, M, Bernstein, J A, Bizjak, M, Boccon-Gibod, I, Bonnekoh, H, Bouillet, L, Brzoza, Z, Busse, P, Campos, R A, Carne, E, Conlon, N, Criado, R F, de Souza Lima, E M, Demir, S, Dissemond, J, Doğan Günaydın, S, Dorofeeva, I, Ensina, L F, Ertaş, R, Ferrucci, S M, Figueras-Nart, I, Fomina, D, Franken, S M, Fukunaga, A, Giménez-Arnau, A M, Godse, K, Gonçalo, M, Gotua, M, Grattan, C, Guillet, C, Inomata, N, Jakob, T, Karakaya, G, Kasperska-Zając, A, Katelaris, C H, Košnik, M, Krasowska, D, Kulthanan, K, Kumaran, M S, Lang, C, Larco-Sousa, J I, Lazaridou, E, Leslie, T A, Lippert, U, Llosa, O C, Makris, M, Marsland, A, Medina, I V, Meshkova, R, Palitot, E B, Parisi, C A S, Pickert, J, Ramon, G D, Rodríguez-Gonzalez, M, Rosario, N, Rudenko, M, Rutkowski, K, Sánchez, J, Schliemann, S, Sekerel, B E, Serpa, F S, Serra-Baldrich, E, Song, Z, Soria, A, Staevska, M, Staubach, P, Tagka, A, Takahagi, S, Thomsen, S F, Treudler, R, Vadasz, Z, Valle, S O R, Van Doorn, M B A, Vestergaard, C, Wagner, N, Wang, D, Wang, L, Wedi, B, Xepapadaki, P, Yücel, E, Zalewska-Janowska, A, Zhao, Z, Zuberbier, T & Maurer, M 2021, ' The global impact of the COVID-19 pandemic on the management and course of chronic urticaria ', Allergy, vol. 76, no. 3, pp. 816-830 . https://doi.org/10.1111/all.14687, Allergy: European Journal of Allergy and Clinical Immunology, 76(3), 816-830. Wiley-Blackwell Publishing Ltd, Allergy, vol. 75, pp. 1-39, 2020., Kocatürk, E, Salman, A, Cherrez-Ojeda, I, Criado, P R, Peter, J, Comert-Ozer, E, Abuzakouk, M, Agondi, R C, Al-Ahmad, M, Altrichter, S, Arnaout, R, Arruda, L K, Asero, R, Bauer, A, Ben-Shoshan, M, Bernstein, J A, Bizjak, M, Boccon-Gibod, I, Bonnekoh, H, Bouillet, L, Brzoza, Z, Busse, P, Campos, R A, Carne, E, Conlon, N, Criado, R F, de Souza Lima, E M, Demir, S, Dissemond, J, Doğan Günaydın, S, Dorofeeva, I, Ensina, L F, Ertaş, R, Ferrucci, S M, Figueras-Nart, I, Fomina, D, Franken, S M, Fukunaga, A, Giménez-Arnau, A M, Godse, K, Gonçalo, M, Gotua, M, Grattan, C, Guillet, C, Inomata, N, Jakob, T, Karakaya, G, Kasperska-Zając, A, Katelaris, C H, Košnik, M, Krasowska, D, Kulthanan, K, Kumaran, M S, Lang, C, Larco-Sousa, J I, Lazaridou, E, Leslie, T A, Lippert, U, llosa, O C, Makris, M, Marsland, A, Medina, I V, Meshkova, R, Palitot, E B, Parisi, C A S, Pickert, J, Ramon, G D, Rodríguez-Gonzalez, M, Rosario, N, Rudenko, M, Rutkowski, K, Sánchez, J, Schliemann, S, Sekerel, B E, Serpa, F S, Serra-Baldrich, E, Song, Z, Soria, A, Staevska, M, Staubach, P, Tagka, A, Takahagi, S, Thomsen, S F, Treudler, R, Vadasz, Z, Valle, S O R, Van Doorn, M B A, Vestergaard, C, Wagner, N, Wang, D, Wang, L, Wedi, B, Xepapadaki, P, Yücel, E, Zalewska-Janowska, A, Zhao, Z, Zuberbier, T & Maurer, M 2021, ' The global impact of the COVID-19 pandemic on the management and course of chronic urticaria ', Allergy: European Journal of Allergy and Clinical Immunology, vol. 76, no. 3, pp. 816-830 . https://doi.org/10.1111/all.14687, Allergy, Allergy, 76(3), 816-830. Wiley-Blackwell, ALLERGY, r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau, Fundacion Sancho el Sabio Fundazioa (FSS)
- Publication Year :
- 2021
-
Abstract
- Introduction: the COVID-19 pandemic dramatically disrupts health care around the globe. The impact of the pandemic on chronic urticaria (CU) and its management are largely unknown. Aim: to understand how CU patients are affected by the COVID-19 pandemic; how specialists alter CU patient management; and the course of CU in patients with COVID-19. Materials and methods: our cross-sectional, international, questionnaire-based, multicenter UCARE COVID-CU study assessed the impact of the pandemic on patient consultations, remote treatment, changes in medications, and clinical consequences. Results: the COVID-19 pandemic severely impairs CU patient care, with less than 50% of the weekly numbers of patients treated as compared to before the pandemic. Reduced patient referrals and clinic hours were the major reasons. Almost half of responding UCARE physicians were involved in COVID-19 patient care, which negatively impacted on the care of urticaria patients. The rate of face-to-face consultations decreased by 62%, from 90% to less than half, whereas the rate of remote consultations increased by more than 600%, from one in 10 to more than two thirds. Cyclosporine and systemic corticosteroids, but not antihistamines or omalizumab, are used less during the pandemic. CU does not affect the course of COVID-19, but COVID-19 results in CU exacerbation in one of three patients, with higher rates in patients with severe COVID-19. Conclusions: the COVID-19 pandemic brings major changes and challenges for CU patients and their physicians. The long-term consequences of these changes, especially the increased use of remote consultations, require careful evaluation.<br />Novartis; Sanofi; Menarini Universidad Espiritu Santo; Takeda; Allakos; AstraZeneca; CSL Behring; Genentech; Pharming; GSK; Shire/Takada; BioCryst; ResTORbio; Pearl Therapeutics, CVS Health; Law offices of Levin; Riback; Adelman; Flangel; Vedder Price; Fresenius; Taiho; Kyowa Kirin; Tanabe; Korin; Uriach Pharma; Instituto Carlos III FEDER; Menarini; Amgen; Thermo Fisher; Avene; ALK‐Abello; Bencard/Allergy Therapeutics; Celgene; Allergopharma; Faes Farma; AbbVie; Janssen; Leo Pharma; Lilly; Roche; Genesis; Menlo Therapeutics; UCB; Pfizer; Almirall; Galderma; Allergika; Beiersdorf; Biocryst; Biogen Idec; BMS; Boehringer‐Ingelheim; Eli‐Lilly; Galderma; Hexal; Klosterfrau; LEO‐Pharma; LETI‐Pharma; L´Oreal; Medice; Octapharma; Pflüger; Pharming; Regeneron; Shire; ALK‐Abello; Fraunhofer‐IZI Leipzig; Hautnetz Leipzig/Westsachsen; MSD; HAL‐Allergy; Bencard; Nestle; Nutricia; Bayer Health Care; FAES; Henkel; Allakos; Argenx; Genentech Menarini; Moxie; Aralez; Celldex
- Subjects :
- Male
0301 basic medicine
STRESS
Exacerbation
UCARE
pandemije
Medizin
Omalizumab
SERUM
chronic urticaria
0302 clinical medicine
Pandemic
Health care
Immunology and Allergy
Chronic Urticaria
treatment
Chronic urticaria
COVID-19
Cyclosporine
SARS-CoV-2
Treatment
zdravljenje
ASSOCIATION
Middle Aged
cyclosporine
omalizumab
pandemic
kronična urtikarija
INFECTIONS
GA(2)LEN
Female
600 Technik, Medizin, angewandte Wissenschaften::610 Medizin und Gesundheit::610 Medizin und Gesundheit
medicine.drug
Adult
medicine.medical_specialty
Adolescent
Coronavirus disease 2019 (COVID-19)
Immunology
udc:616-097
pandemics
ciklosporin
Young Adult
03 medical and health sciences
Patient referral
medicine
Humans
In patient
Patient Reported Outcome Measures
Aged
Internet
business.industry
DEFINITION
Medicine
Allergy
Cross-Sectional Studies
030104 developmental biology
030228 respiratory system
Emergency medicine
business
Subjects
Details
- Language :
- English
- ISSN :
- 01054538 and 13989995
- Volume :
- 76
- Issue :
- 3
- Database :
- OpenAIRE
- Journal :
- Allergy: European Journal of Allergy and Clinical Immunology
- Accession number :
- edsair.doi.dedup.....bb8272d958b9b961ee852c673ded3a04